FDA finalizes guidance for premarket tobacco product applications for electronic nicotine delivery systems as part of commitment to continuing a strong oversight of e-cigarettesJune 11, 2019
FDA approves first chemoimmunotherapy regimen for patients with relapsed or refractory diffuse large B-cell lymphomaJune 10, 2019
FDA permits marketing of first medical device for relief of pain associated with irritable bowel syndrome in patients 11-18 years of ageJune 7, 2019
FDA, FTC take action to protect kids by citing four firms that make, sell flavored e-liquids for violations related to online posts by social media influencers on their behalfJune 7, 2019
Statement on warning for women of childbearing age about possible safety risks of dietary supplements containing vinpocetineJune 5, 2019
FDA approves first treatment for episodic cluster headache that reduces the frequency of attacksJune 4, 2019
Federal court issues decision holding that US Stem Cell clinics and owner adulterated and misbranded stem cell products in violation of the lawJune 4, 2019
FDA announces Project Facilitate to assist physicians seeking access to unapproved therapies for patients with cancerJune 3, 2019
FDA puts company on notice for marketing unapproved stem cell products for treating serious conditionsMay 30, 2019
Statement on FDA’s request for information on requiring fixed-quantity blister packaging for certain opioid pain medicines to help decrease unnecessary exposure to opioidsMay 30, 2019
FDA approves innovative gene therapy to treat pediatric patients with spinal muscular atrophy, a rare disease and leading genetic cause of infant mortalityMay 24, 2019
HHS Proposes to Revise ACA Section 1557 Rule to Enforce Civil Rights in Healthcare, Conform to Law, and Eliminate Billions in Unnecessary CostsMay 24, 2019
FDA permits marketing of first diagnostic test to aid in detecting prosthetic joint infectionsMay 23, 2019
